Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future-Reference-Cited by-同舟云学术

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

Published:2021-01-28 Issue:2 Volume:5 Page:e524
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Heine Renaud,Thielen Frederick W.,Koopmanschap Marc,Kersten Marie José,Einsele Hermann,Jaeger Ulrich,Sonneveld Pieter,Sierra Jorge,Smand Carin,Uyl-de Groot Carin A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference29 articles.

1. Evolution of CAR T-cell immunotherapy in terms of patenting activity.;Jürgens;Nat Biotechnol,2019

2. CAR-T cells: future perspectives.;Charrot;HemaSphere,2019

3. Epidemiology of follicular lymphoma.;Cerhan;Hematol Oncol Clin North Am,2020

4. Mantle cell lymphoma: contemporary diagnostic and treatment perspectives in the age of personalized medicine.;Sandoval-Sus;Hematol Oncol Stem Cell Ther,2017

5. Diffuse large B-cell lymphoma.;Li;Pathology,2018

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability and financing of CAR-T cell therapies: A cross-country comparative analysis;Health Policy;2024-11

2. ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights;Frontiers in Immunology;2024-09-05

3. Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in Germany;2024-09-03

4. Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma;Transplantation and Cellular Therapy;2024-09

5. Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐T;Biotechnology and Bioengineering;2024-07-04